SG11202106638UA - Method of diagnosing gastric cancers using micrornas - Google Patents
Method of diagnosing gastric cancers using micrornasInfo
- Publication number
- SG11202106638UA SG11202106638UA SG11202106638UA SG11202106638UA SG11202106638UA SG 11202106638U A SG11202106638U A SG 11202106638UA SG 11202106638U A SG11202106638U A SG 11202106638UA SG 11202106638U A SG11202106638U A SG 11202106638UA SG 11202106638U A SG11202106638U A SG 11202106638UA
- Authority
- SG
- Singapore
- Prior art keywords
- micrornas
- gastric cancers
- diagnosing gastric
- diagnosing
- cancers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201811421Q | 2018-12-19 | ||
PCT/SG2019/050621 WO2020130944A1 (fr) | 2018-12-19 | 2019-12-17 | Procédé |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202106638UA true SG11202106638UA (en) | 2021-07-29 |
Family
ID=71102949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202106638UA SG11202106638UA (en) | 2018-12-19 | 2019-12-17 | Method of diagnosing gastric cancers using micrornas |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220081722A1 (fr) |
EP (1) | EP3899052A4 (fr) |
JP (1) | JP7512285B2 (fr) |
CN (1) | CN113454242A (fr) |
SG (1) | SG11202106638UA (fr) |
WO (1) | WO2020130944A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118685365A (zh) * | 2024-08-23 | 2024-09-24 | 昆明医科大学附属口腔医院(云南省口腔医院) | miR-423-5p高丰度工程化囊泡的构建及应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2257647B1 (fr) * | 2008-02-28 | 2016-09-14 | The Ohio State University Research Foundation | Procédés et compositions fondés sur micro arn pour le diagnostic du cancer de l'estomac |
EP4137586A1 (fr) * | 2014-08-07 | 2023-02-22 | Agency for Science, Technology and Research | Biomarqueur à base de microarn utilisable en vue du diagnostic du cancer gastrique |
CN108048574A (zh) * | 2017-10-13 | 2018-05-18 | 江苏为真生物医药技术股份有限公司 | 胃癌外泌体miRNA分子标记的应用及其试剂盒 |
-
2019
- 2019-12-17 EP EP19899358.6A patent/EP3899052A4/fr active Pending
- 2019-12-17 CN CN201980091799.0A patent/CN113454242A/zh active Pending
- 2019-12-17 US US17/415,881 patent/US20220081722A1/en active Pending
- 2019-12-17 JP JP2021535309A patent/JP7512285B2/ja active Active
- 2019-12-17 WO PCT/SG2019/050621 patent/WO2020130944A1/fr unknown
- 2019-12-17 SG SG11202106638UA patent/SG11202106638UA/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN113454242A (zh) | 2021-09-28 |
EP3899052A4 (fr) | 2023-02-22 |
WO2020130944A1 (fr) | 2020-06-25 |
JP7512285B2 (ja) | 2024-07-08 |
JP2022514598A (ja) | 2022-02-14 |
EP3899052A1 (fr) | 2021-10-27 |
US20220081722A1 (en) | 2022-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10202011339RA (en) | Microrna biomarker for the diagnosis of gastric cancer | |
GB201511152D0 (en) | Method of diagnosing bladder cancer | |
HUE048369T2 (hu) | Diagnosztikai eljárás végbélrák kimutatására | |
ZA201908158B (en) | Novel method for synthesizing amanitins | |
GB201801768D0 (en) | Synthesis method | |
GB201806072D0 (en) | Methods of manufacture | |
GB201804594D0 (en) | Bonegraft substituteand method of manufacture | |
EP3894768C0 (fr) | Procédés de cryo-durcisssement | |
GB201802839D0 (en) | Method of manufacture | |
SG10201913528PA (en) | Methods of diagnosing cancer | |
GB2586061B (en) | Arming apparatus | |
PL3572159T3 (pl) | Sposoby formowania przewodów ultraprzewodzących | |
PL3755681T3 (pl) | Sposób wytwarzania 4-boronofenyloalaniny | |
SG11202106638UA (en) | Method of diagnosing gastric cancers using micrornas | |
ZA202003113B (en) | METHOD OF SYNTHESISING 6-DEOXY-6-AMINO-ß-D-GLUCOPYRANOSIDE-CONTAINING POLYMERS | |
GB201704089D0 (en) | Method of manufacture | |
ZA201906270B (en) | An improved method for high level production of crm | |
PL3844309T3 (pl) | Sposób diagnozowania nowotworów złośliwych układu moczowo-płciowego | |
GB2568476B (en) | Method of image production | |
GB201704816D0 (en) | Method of manufacture | |
SG10201908792QA (en) | Method of making polymers | |
GB201809456D0 (en) | Method of diagnosis | |
GB2578309B (en) | Method of stimulating hydrocarbon production | |
GB201809404D0 (en) | Method of synthesis | |
GB201916838D0 (en) | Method of diagnosis |